Sorrento Therapeutics Inc (NASDAQ:SRNE)
| 5.35 Data as of Jul 23 |  -0.09 / -1.65%Today’s Change | 4.75 Today|||52-Week Range 16.40 | -33.95% Year-to-Date |
Stock Price Forecast
The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 14.00, with a high estimate of 35.00 and a low estimate of 9.00. The median estimate represents a +161.68% increase from the last price of 5.35.
Analyst Recommendations
The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since July, when it was unchanged from a rating.Move your mouse over past
months for detail
Earnings and Sales Forecasts
Current Quarter
Earnings per Share
-$0.38
-$0.38
Sales
$100.0K
$100.0K
Reporting Date
Sep 03
Sep 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.
Growthquarterly 13.64%
Growthannually 1.60%
Sales
Growthquarterly -89.75%
Growthannually 301.16%
.
